The Gross Margin of Clinuvel Pharmaceuticals Ltd (CUV.AX) is 101.16%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-06-30 | 101.16% |
| 2023-06-30 | 109.35% |
| 2022-06-30 | 97.95% |
| 2021-06-30 | 103.93% |
| 2020-06-30 | 97.44% |